31
Dec
In a revolutionary stride for cancer treatment in India, Tata Hospital and a Bangalore-based laboratory have collaboratively developed the country's first oral suspension medication for leukemia patients. This groundbreaking achievement signals a significant leap forward in accessible and patient-friendly cancer care. Innovative Collaboration for Patient-Friendly Treatment: The collaboration between Tata Hospital and the Bangalore lab stands as a testament to the power of innovative partnerships in healthcare. By pooling their expertise, these institutions have pioneered a patient-friendly alternative for leukemia treatment, addressing the challenges associated with traditional intravenous methods. Overcoming Treatment Hurdles: Traditional leukemia treatments often involve intravenous administration, posing…